← Back
$SNDX All transactions

Syndax Pharmaceuticals Inc

▼ SELL

$ Value

$72K

Shares

3,410

Price

$21

Filed

Feb 10

Insider

Name

Goldan Keith A.

Title

Chief Financial Officer

CIK

0001495411

Roles

Officer

Transaction Details

Transaction Date

2026-02-09

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

140,429

Footnotes

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.

Filing Info

Accession No.

0001193125-26-043813

Form Type

4

Issuer CIK

0001395937

Goldan Keith A.'s History

Date Ticker Type Value
2026-04-01 ABEO A $0
2026-02-09 SNDX $72K
2026-02-06 SNDX $43K
2026-02-04 SNDX A $0
2026-02-04 SNDX A $0
2026-02-04 SNDX A $2.4M
2026-01-30 SNDX J $10K
2025-12-01 SNDX G $0
2025-07-31 SNDX J $10K
2025-07-16 SNDX $12K

Other Insiders at SNDX (90d)

Insider Bought Sold Last
Podlesak Dennis 2026-02-04
Katkin Keith 2026-02-04
Legault Pierre 2026-02-04
Goldan Keith A.
Chief Financial Officer
$43K 2026-02-06
Metzger Michael A
Chief Executive Officer
$514K 2026-02-09
Huber Martin H. Jr. 2026-02-04
Jarrett Jennifer 2026-02-04
Rizo Aleksandra 2026-02-04
Botwood Nicholas A.J.
Head of R&D, CMO
2026-02-04